Silence Therapeutics plc
SLN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36,190 | -$50,310 | -$50,334 | -$61,889 |
| Dep. & Amort. | $593 | $498 | $596 | $576 |
| Deferred Tax | $845 | $0 | $688 | $5,953 |
| Stock-Based Comp. | $13,025 | $13,050 | $12,686 | $11,650 |
| Change in WC | -$33,023 | -$11,662 | -$19,397 | $52,427 |
| Other Non-Cash | -$12,890 | $9,074 | -$1,283 | $468 |
| Operating Cash Flow | -$67,640 | -$39,350 | -$57,044 | $9,186 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$211 | -$45 | -$173 | -$1,769 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$139,167 | -$20,666 | -$19,953 | $0 |
| Inv. Sales/Matur. | $0 | $36,183 | $0 | $13,496 |
| Other Inv. Act. | $117,412 | $958 | -$372 | -$18 |
| Investing Cash Flow | -$21,966 | $16,430 | -$20,498 | $11,709 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$174 | $0 | -$285 |
| Stock Issued | $142,087 | $25,329 | $52,581 | $41,733 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$0 |
| Financing Cash Flow | $142,087 | $25,155 | $52,581 | $41,449 |
| Forex Effect | $60 | -$3,020 | -$8,119 | -$142 |
| Net Chg. in Cash | $52,541 | -$785 | -$33,080 | $62,202 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $68,789 | $54,816 | $99,351 | $37,046 |
| End Cash | $121,330 | $54,031 | $66,271 | $99,248 |
| Free Cash Flow | -$67,851 | -$39,395 | -$57,589 | $7,385 |